|
Novo-nordisk A S Adr
(NVO)
|
19.1 |
$99M |
|
692k |
142.74 |
|
Eli Lilly & Co.
(LLY)
|
16.2 |
$84M |
|
93k |
905.38 |
|
Lilly Eli & Co option Put Option
|
13.1 |
$68M |
|
75k |
905.38 |
|
Merck & Co
(MRK)
|
10.6 |
$55M |
|
443k |
123.80 |
|
Novo-nordisk A S Adr Put Option
|
8.6 |
$44M |
|
310k |
142.74 |
|
Viking Therapeutics
(VKTX)
|
4.6 |
$24M |
|
453k |
53.01 |
|
Astrazeneca Sponsored Adr
(AZN)
|
2.9 |
$15M |
|
191k |
77.99 |
|
Intra Cellular Therapies
(ITCI)
|
2.9 |
$15M |
|
217k |
68.49 |
|
Vertex Pharmaceuticals Incorporated
(VRTX)
|
1.7 |
$8.9M |
|
19k |
468.72 |
|
Alnylam Pharmaceuticals
(ALNY)
|
1.6 |
$8.5M |
|
35k |
243.00 |
|
Viking Therapeutics Inc call Call Option
|
1.5 |
$8.0M |
|
150k |
53.01 |
|
Insmed Com Par $.01 Put Option
|
1.4 |
$7.4M |
|
110k |
67.00 |
|
Axsome Therapeutics
(AXSM)
|
1.4 |
$7.1M |
|
88k |
80.50 |
|
Argenx Se Sponsored Adr
(ARGX)
|
1.3 |
$6.5M |
|
15k |
430.04 |
|
Neurocrine Biosciences
(NBIX)
|
1.2 |
$6.2M |
|
45k |
137.67 |
|
Vaxcyte
(PCVX)
|
1.1 |
$5.8M |
|
76k |
75.51 |
|
Protagonist Therapeutics
(PTGX)
|
0.8 |
$4.3M |
|
124k |
34.65 |
|
Dyne Therapeutics
(DYN)
|
0.8 |
$4.2M |
|
120k |
35.29 |
|
Soleno Therapeutics
(SLNO)
|
0.7 |
$3.9M |
|
94k |
40.80 |
|
Crinetics Pharmaceuticals In
(CRNX)
|
0.7 |
$3.8M |
|
86k |
44.79 |
|
Insmed Com Par $.01
(INSM)
|
0.7 |
$3.6M |
|
53k |
67.00 |
|
Ocular Therapeutix
(OCUL)
|
0.7 |
$3.4M |
|
500k |
6.84 |
|
Ionis Pharmaceuticals
(IONS)
|
0.6 |
$3.0M |
|
63k |
47.66 |
|
Merus N V
(MRUS)
|
0.6 |
$3.0M |
|
50k |
59.17 |
|
Celldex Therapeutics Com New
(CLDX)
|
0.5 |
$2.8M |
|
75k |
37.01 |
|
Apogee Therapeutics
(APGE)
|
0.4 |
$2.3M |
|
58k |
39.35 |
|
Springworks Therapeutics
(SWTX)
|
0.4 |
$2.0M |
|
54k |
37.67 |
|
Ideaya Biosciences
(IDYA)
|
0.4 |
$1.9M |
|
54k |
35.11 |
|
Verona Pharma Sponsored Ads
(VRNA)
|
0.4 |
$1.9M |
|
131k |
14.46 |
|
Xenon Pharmaceuticals
(XENE)
|
0.3 |
$1.6M |
|
40k |
38.99 |
|
Mereo Biopharma Group Spon Ads
(MREO)
|
0.3 |
$1.5M |
|
421k |
3.60 |
|
Charles River Laboratories
(CRL)
|
0.3 |
$1.4M |
|
6.9k |
206.58 |
|
Kura Oncology
(KURA)
|
0.2 |
$1.2M |
|
57k |
20.59 |
|
Newamsterdam Pharma Company Ordinary Shares
(NAMS)
|
0.2 |
$1.0M |
|
54k |
19.21 |
|
Ascendis Pharma A/s Sponsored Adr
(ASND)
|
0.2 |
$1.0M |
|
7.4k |
136.38 |
|
Silence Therapeutics Ads
(SLN)
|
0.2 |
$997k |
|
53k |
19.00 |
|
Syndax Pharmaceuticals
(SNDX)
|
0.2 |
$991k |
|
48k |
20.53 |
|
Keros Therapeutics
(KROS)
|
0.2 |
$914k |
|
20k |
45.70 |
|
Corbus Pharmaceuticals Hldgs Com New
(CRBP)
|
0.2 |
$905k |
|
20k |
45.25 |
|
Eyepoint Pharmaceuticals Com New
(EYPT)
|
0.2 |
$883k |
|
102k |
8.70 |
|
Annexon
(ANNX)
|
0.1 |
$723k |
|
148k |
4.90 |
|
Larimar Therapeutics
(LRMR)
|
0.1 |
$656k |
|
91k |
7.25 |
|
Disc Medicine
(IRON)
|
0.1 |
$606k |
|
13k |
45.07 |
|
Pliant Therapeutics
(PLRX)
|
0.1 |
$538k |
|
50k |
10.75 |
|
Madrigal Pharmaceuticals
(MDGL)
|
0.1 |
$436k |
|
1.6k |
280.16 |
|
Sarepta Therapeutics
(SRPT)
|
0.1 |
$411k |
|
2.6k |
158.00 |